Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Zimberelimab

Review the clinical trials studying zimberelimab on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-15 of 15

Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
Status: Active
Location: 7 locations
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Status: Active
Location: 16 locations
Gemcitabine, Cisplatin, Quemliclustat and Zimberelimab for the Treatment of Patients with Advanced, Recurrent or Metastatic Biliary Tract Cancer
Status: Active
Location: 5 locations
Stereotactic Body Radiation Therapy plus Zimberelimab with or without Quemliclustat and Etrumadenant before Surgery for the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer, The AIRPanc Trial
Status: Active
Location: 3 locations
Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma.
Status: Active
Location: 2 locations
Zimberelimab and Quemliclustat in Combination with Chemotherapy for the Treatment of Patients with Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Status: Active
Location: 2 locations
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
Status: Active
Location: 2 locations
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Pemetrexed, Etrumadenant, and Zimberelimab for the Treatment of Advanced or Metastatic Urothelial Carcinoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Zimberelimab and Domvanalimab for the Treatment of Relapsed or Refractory Melanoma
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Evaluation of Zimberelimab, Etrumadenant, Quemliclustat and Stereotactic Body Radiation Therapy for the Treatment of Hormone Sensitive Oligometastatic Prostate Cancer
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
Study of Novel Treatment Combinations in Patients With Lung Cancer
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Stereotactic Radiation with Sacituzumab Govitecan and Zimberelimab for the Treatment of Patients with Metastatic Triple Negative Breast Cancer with Brain Metastases, TARGET-TNBC Trial
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Status: Active
Location: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Combination Maintenance Immunotherapy Versus Maintenance Chemotherapy for the Treatment of Metastatic Pancreatic Cancer
Status: Temporarily Closed to Accrual
Location: 2 locations